Celcuity’s gedatolisib doubled progression-free survival versus standard of care in certain patients with advanced breast ...

A three-drug regimen incorporating AstraZeneca's immune checkpoint inhibitors Imfinzi and Imjudo has reduced the risk of ...

“Donald Trump endorsed Mike Mazzei in this race because their conservative policy goals are aligned,“ Speno said. “President ...

Adam Kittai, MD, breaks down the evolving landscape of CLL sequencing—from venetoclax retreatment to triplet regimens. As he ...

New pill offers hope for patients with incurable blood cancer - About 6,200 people every year in the UK are diagnosed with ...

New NHS blood cancer pill could help patients live well for longer - Mezigdomide works by attaching to a specific protein in the body ...

CHICAGO -- Adding a novel cereblon E3 ligase modulation (CELMoD) drug to a standard multiple myeloma regimen significantly improved progression-free survival (PFS) in a vulnerable population of ...

From rookies like Fernando Mendoza to experienced former starters, here are the players one rep away from being QB1.

$1 million awarded through the SETI Institute’s STRIDE (Support Technology, Research, Innovation, Development, and Education) ...

A copypasta (copy-and-paste) circulating on Facebook claiming that in a “landmark ruling,” the Supreme Court “officially ...

In this global phase 3 trial, investigators assessed tafasitamab and lenalidomide plus R-CHOP versus standard-of-care R-CHOP for safety and efficacy in patients with previously untreated DLBCL.

32 times people realized they'd just picked a fight with the wrong person.